Number of the records: 1  

Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial

  1. 1.
    SYSNO ASEP0551302
    Document TypeA - Abstract
    R&D Document TypeThe record was not marked in the RIV
    R&D Document TypeNení vybrán druh dokumentu
    TitleDendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial
    Author(s) Rob, L. (CZ)
    Mallmann, P. (DE)
    Knapp, P. (PL)
    Melichar, B. (CZ)
    Klat, J. (CZ)
    Minář, L. (CZ)
    Novotný, Z. (CZ)
    Bartůňková, J. (CZ)
    Spíšek, R. (CZ)
    Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
    Bin Hassan, H. I. (CZ)
    Cibula, D. (CZ)
    Source TitleJournal of Clinical Oncology - ISSN 0732-183X
    Roč. 36, 15 S (2018), s. 5509
    Number of pages1 s.
    Languageeng - English
    CountryGB - United Kingdom
    UT WOS000442916002205
    DOI10.1200/JCO.2018.36.15_suppl.5509
    WorkplaceInstitute of Computer Science
    ContactTereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800
    Year of Publishing2022
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.